Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies.
about
Efficacy of high-dose amoxicillin-clavulanate against experimental respiratory tract infections caused by strains of Streptococcus pneumoniaePharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model.Comparison of standard versus double dose of amoxicillin in the treatment of non-severe pneumonia in children aged 2-59 months: a multi-centre, double blind, randomised controlled trial in Pakistan.Pharmacokinetic and pharmacodynamic parameters for antimicrobial effects of cefotaxime and amoxicillin in an in vitro kinetic model.Treatment of Community-Acquired Pneumonia: Are All Countries Treating Children in the Same Way? A Literature Review.
P2860
Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies.
description
1997 nî lūn-bûn
@nan
1997 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Rationale behind high-dose amo ...... vitro pharmacodynamic studies.
@ast
Rationale behind high-dose amo ...... vitro pharmacodynamic studies.
@en
type
label
Rationale behind high-dose amo ...... vitro pharmacodynamic studies.
@ast
Rationale behind high-dose amo ...... vitro pharmacodynamic studies.
@en
prefLabel
Rationale behind high-dose amo ...... vitro pharmacodynamic studies.
@ast
Rationale behind high-dose amo ...... vitro pharmacodynamic studies.
@en
P2093
P2860
P356
P1476
Rationale behind high-dose amo ...... vitro pharmacodynamic studies
@en
P2093
P2860
P304
P356
10.1128/AAC.41.9.1926
P407
P577
1997-09-01T00:00:00Z